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Abstract 
Aim: The Research Outcome Study in Ireland (ROSIE) is the first large-scale, prospective, multi-
site, drug treatment outcome study in Ireland. 
Method: Using a structured questionnaire, the substance use, health, crime and social problems of 
404 opiate users were assessed at treatment intake (6 months, 1 year and 3 years later). 
Findings: While the majority of study participants were opiate users, poly-drug use was the norm 
(76%, n=308). Most participants had a history of injecting drug use (77%, n=308), however only 
42% (n=170) reported injecting in the preceding 90 days. Participants reported a range of mental 
and physical health complaints and extensive contact with social care services. High crime rates 
were observed. Analysis revealed differences in the characteristics and substance use of 
participants across treatment modality. 
Conclusions: The range and severity of problems affecting individuals commencing treatment for 
their problem drug use highlights the complex needs of the cohort. These problems create 
substantial costs for providers of social care services in Ireland and can affect treatment outcomes. 
 
Keywords: Treatment, outcome, opiates, crime, health 
 
Introduction 
In Ireland estimates of the numbers of opiate users have remained relatively consistent at 14,000 
from 1996 (Comiskey, 2001) to the present (Kelly, Carvalho, & Teljeur, 2003). However, the 
numbers presenting for treatment over the same time period have more then doubled. Recognition 
of the harms associated with problem drug use, and the chronic nature of this condition, has lead to 
increased availability of treatment and/or rehabilitative services in Ireland under the National Drug 
Strategy (2001). Although international studies support the overall effectiveness of established 
treatment options available for problem drug users (Anglin, Hser, & Grella, 1997; Gossop, Marsden, 
Stewart, & Kidd, 2003; Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997; Teesson et al., 
2006), to date, no national longitudinal data have been available to determine the effectiveness of 
such treatment options in the Irish context. 
 
Treatment evaluation research has traditionally relied upon outcome studies as a logical first step in 
understanding effectiveness. The Research Outcome Study in Ireland (ROSIE) is the country’s first 
national, longitudinal drug treatment outcome study. The study will provide extensive information 
about the pre-treatment problems of individuals being treated in the national drug treatment system 
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and will make available outcome data on the impact of treatment 6 months, 1 year and 3 years 
post-treatment intake. This study is part of an established research tradition and follows similar 
international studies such as DATOS (http://www.datos.org/), NTORS and more recently DTORS 
(http:// www.dtors.org.uk/NTORS.aspx) and DORIS (http://www.gla.ac.uk/drugmisuse/DORIS.html). 
 
This paper provides a detailed demographic, drug using and social profile of 404 opiate users and 
highlights the types of problems presented by this large, national cohort of service users. 
Differences between the characteristics and problems presented by these service users at 
treatment intake, across the main treatment modalities are also examined. 
 
Methods 
 
Agencies 
Between September 2003 and July 2004, 404 new drug treatment clients completed baseline 
interviews for the ROSIE study. Recruitment occurred in both in-patient (hospitals, residential 
programmes and prisons) and out-patient settings (community and health board clinics, and GPs), 
across four modalities: methadone (53%, n=215); supervised detoxification programmes (20%, 
n=81); abstinence-based programmes (20%, n=82); and needle exchanges (7%, n=26). All four 
modalities of treatment were available to clients within some of the larger treatment agencies. 
Within the abstinence-based modality baseline study recruitment was carried out in twelve 
abstinence-based treatment settings; nine of which were residential drug treatment programmes 
and three were non-residential facilities. The residential programmes were provided by a number of 
different organizations and were based on different ideologies, for example, 12-Step and Minnesota 
Model-type treatment, a therapeutic community and Christian-based programmes. Treatment length 
within these programmes varied from short term (4 weeks) to long-term (over 1 year). 
 
Treatment agencies were purposively (not randomly) sampled to reflect the known geographical 
spread of provision and range of services. In total, 44 agencies providing approximately 54 services 
located in rural, urban and inner-city areas of Ireland were involved in the study. Two criteria for 
agency participation were location of the service, and capacity to recruit individuals to the study 
within the restricted time period. Many agencies were full to capacity and were unable to facilitate 
new clients over the study period, hence recruitment numbers in these agencies were very low. 
 
Participants 
Client eligibility criteria for the study included: (a) being over 18 years of age; (b) starting a new 
treatment episode; (c) prepared to consent to the tracking/ follow-up procedures; and (d) prepared 
to provide a range of locator information. The study design did not include random allocation of 
participants to treatment. Prior to commencing baseline interviews potential participants were given 
an information sheet about the research, were fully informed of the study requirements and asked 
to sign a consent form. Individuals were not financially reimbursed at baseline interview. In this 
paper, data is first presented for the study population. When comparisons were made across 
modality, individuals recruited through needle exchange (n=26) were excluded. 
 
Coverage 
At a national level, a database on all drug treatment episodes in a calendar year are maintained by 
the National Drug Treatment Reporting System (NDTRS) of the Drug Misuse Research Division of 
the Health Research Board. Compliance with the NDTRS requires that one form be completed for 
each person who received treatment for problematic drug use at each treatment centre. Service 
providers collect data at an agency level and the staff of the NDTRS compiles anonymous 
aggregated data at national level. 
 
NDTRS reports that there were 4900 cases commencing/recommencing treatment for problem drug 
use (not specifically opiate use) in 2003, giving the ROSIE study a minimum national coverage rate 
of 8.2% of all new treatments. In addition, 1265 of these cases commenced/recommenced 
methadone treatment. As 215 of the ROSIE participants were recruited within the methadone 
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modality, the study has a national coverage rate of approximately 17% of all new methadone 
treatments. The NDTRS reports that 682 of the 4900 cases commenced a detoxification 
programme. Eighty-one ROSIE participants were recruited from this modality, giving a national 
coverage of approximately 12%. The NDTRS figures are based on a calendar year, and data for 
2004 is at present unavailable. Given this limitation, the data do provide some information on the 
scale of the ROSIE study. The coverage rates within ROSIE are well in excess of other national 
treatment outcome studies, where rates are seldom published, but are estimated to be in single 
figures and below 5%. 
 
Instrument 
A structured questionnaire assessed a range of participant characteristics. Data were based on 
participants self-report, a valid and reliable methodology when undertaking research on such a 
cohort (Del Coca & Noll, 2000). The main outcome measures were drug-using behaviour, physical 
and mental health, social functioning and crime. The research instrument contained items and 
scales developed specifically for the study and measures adapted from published instruments 
(including MAP and OPI Health Scale). In addition to lifetime measures, data were collected for the 
90 days prior to interview. A team of trained interviewers from the National University of Ireland, 
Maynooth, administered all questionnaires. Baseline interviews took approximately 1 hour to 
complete. A pilot study of 20 interviews was completed to highlight and measure any interviewer 
variability and throughout the study all interviewers were trained by the same trainer. In addition, in 
order to ensure data quality, a quality assurance audit of all primary data was conducted at 
pertinent intervals. 
 
Statistical analysis 
Continuous variables were analysed using means, standard deviation and one-way analysis of 
variance (ANOVA). Post hoc differences between groups were determined using Tukey’s HSD test. 
Statistical analysis of categorical variables was conducted using frequencies and chi-square tests. 
Missing data were handled by excluding the cases from the particular analysis. All statistical 
analysis was conducted using SPSS (version 11.0) for windows. 
 
Results 
 
Demographics 
One quarter of the study population was female (n=102). The average age of participants was 28 
years (median 27, range 18–57 years). On average respondents reported leaving school at 15 
years, and 28% of the population were ‘early school leavers’—left school before the age of 15 
years. Analysis revealed that current levels of employment were low; only 16% of the population 
was employed (either full time or part time) at baseline interview, while 21% had been employed 
over the three months prior to baseline interview. The main source of income for the majority of 
participants (77%) was social welfare payments. Less than one third of the cohort were living in the 
family home at the time of the baseline interview, and 25% were in their own or rented 
accommodation. Eight percent of the study population were homeless at baseline interview, 
however, 18% reported a period of homelessness over the preceding 3 months. The majority of 
respondents (56%, n=216) reported having children under the age of 18 years. However, over half 
of the participants with children (56%, n=121) did not have their children in their care. 
 
Illicit drug use 
Table I illustrates that participants reported using a range of substances in their lifetime. Opiates 
were the drugs most frequently used over the 90 days prior to interview (81%, n=316). Heroin was 
used by 77% of the respondents, and 41% used non-prescribed methadone. Poly-drug use was the 
norm (76%, n=308). 
 
The majority of participants (77%, n=308) reported having ever injected a drug, and most reported 
engaging in some form of injecting risk behaviour in their lifetime; borrowing (63%, n=178) and 
lending (53%, n=152) used needles/ syringes, sharing filters/spoons/flush water (63%, n=179) and 
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reusing own injecting equipment (88%, n=250). Forty-two percent of the population (n=170) 
reported injecting in the preceding 90 days. These individuals injected on average 47 out of the 90 
days, and 15% (n=46) were daily injectors. Levels of recent injecting risk behaviour were 
substantially lower than lifetime levels. For example, only 12% (n=21) of the injecting population 
reported borrowing, and 6% (n=17) reported lending used needles/syringes in the preceding 90 
days. Forty-six percent (n=181) of the study population reported having had an accidental overdose 
at least once in their lifetime. Levels of recent (last 90 days) overdose were substantially lower at 
7% (n=26). Alcohol use 
 
Over half the cohort (54%, n=204) drank alcohol in the preceding 90 days. Male drinkers 
consumed, in a typical drinking day, an average of 19 units (SD=18), while females consumed an 
average of 12 units (SD=12). Forty-two percent (n=157) of the cohort were ‘heavy drinkers’; defined 
as consuming six or more units on an average drinking day for a women and 8 or more units on an 
average day for a male. These data excluded those who did not drink at all. 
 
Table I. Drug use for study population (n=404). 
 Ever used Recent use 
(last 90 days) 
Mean age first 
used 
Reported 
problematic use 
Mean age of first 
problematic use 
 % (n) % (n) Mean (SD) % (n) Mean (SD) 
Heroin 99 (398) 77 (306) 18.3 (4.6) 92 (355) 20.3 (4.9) 
Cannabis 97 (375) 64 (243) 14.3 (3.3) 30 (102) 17.5 (5.3) 
Cocaine 92 (348) 44 (179) 19.7 (4.5) 38 (123) 22.0 (4.1) 
Ecstasy 90 (314) 12 (46) 17.6 (4.5) 36 (103) 17.6 (3.8) 
a Non-prescribed 
benzodiazepines 
87 (324) 44 (174) 20.5 (4.5) 42 (120) 20.5 (4.5) 
Non-prescribed 
methadone 
86 (335) 41 (161) 20.4 (5.3) 32 (96) 22.0 (6.1) 
Amphetamine 80 (278) 4 (17) 17.4 (3.5) 24 (60) 17.2 (2.9) 
Crack 59 (212) 15 (59) 22.6 (4.8) 29 (55) 22.2 (4.2) 
Note: a This includes the misuse of prescribed benzodiazepines. 
 
 
Contact with treatment service 
Most participants (87%, n=352) had previously sought treatment for their drug use. Previous 
treatment included: methadone maintenance (59%, n=236); supervised detoxification (52%, 
n=205); counselling (61%, n=243); and residential drug treatment (32%, n=127). Participants also 
reported contacting other social care services over the previous 12 months. This included attending 
an A&E Department (43%, n=174), a GP (52%, n=207), an out-patients’ appointment (22%, n=89), 
a hospital admission (26%, n=104), contact with housing/ homeless services (28%, n=111), and 
social welfare services (47%, n=189).  
 
Physical and mental health 
Participants reported suffering from a range of physical and mental health complaints. The most 
frequently reported physical health symptoms were poor appetite (72%, n=268) and feeling 
tired/fatigued (72%, n=268). One third of the cohort reported suffering from these health problems 
on a daily basis. Regarding mental health complaints, over half the cohort reported feeling hopeless 
about the future (56%, n=196), feelings of worthlessness (53%, n=188), and having no interest in 
things (57%, n=206). In addition, 25% (n=88) of respondents had suicidal thoughts over the 90 days 
prior to interview. One third of the cohort reportedly attempted suicide in the past (33%, n=127) and 
19% (n=39) attempted suicide in the preceding six months. 
 
Crime 
The vast majority of participants (90%, n=339) committed some form of crime in their lifetime 
(excluding drug possession and driving-related offences); 76% committed an acquisitive crime 
(n=291) and 70% dealt/supplied drugs (n=243). The proportions of respondents reporting recent 
involvement in crime were substantially lower across all categories of offences. For example, only 
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28% (n=105) of the cohort reportedly committed an acquisitive crime in the 90 days prior to baseline 
interview, while 30% (n=109) reportedly dealt drugs over the same time period. 
 
Seventy-six percent (n=285) of participants reported having been arrested for an offence, 18% 
(n=69) reported an arrest in the preceding 90 days. However, 48% of respondents reported having 
outstanding legal problems at treatment intake (n=219). In addition levels of imprisonment were 
high, and 65% (n=253) of respondents had a prison history. 
 
Participant differences across treatment modalities 
Table II illustrates the demographic and treatment variables by modality. Significant gender 
differences were observed, with the highest proportion of men being in abstinence-based treatment 
and the lowest in methadone programmes. Participants in the detoxification group were significantly 
younger than those in methadone treatment. Analysis revealed that higher proportions of those in 
methadone treatment were homeless at the time of interview than those in other modalities. 
Participants in this modality were also less likely to report having any educational qualifications and 
were more likely to have children. 
 
 
Table II. Demographic and treatment variables by modality. 
   Modality F/x value P-value   
 Methadone 
(n=215) 
Detoxification 
(n=81) 
Abstinence 
(n=82) 
  
Demographics % (n/SD) % (n/SD) % n   
%Male 68 (147) 77 (62) 89 (73) 13.5 0.00** 
Age (SD) 28 (6.6)a 26 (5.9)a 27 (5.1) 3.7 0.02* 
%No educational 
Qualifications 
40 (82) 22 (18) 21 (17) 17.2 0.00** 
% Currently homeless 12 (25) 3 (2) 1 (1) 175.3 0.00** 
%Inprisoninlast90days 8 (17) 19 (15) 20 (16) 9.7 0.00** 
% Have children 64 (130) 47 (37) 47 (36) 9.5 0.00** 
Treatment variables         
% On waiting list to 
access index treatment 
57 (120) 79 (64) 66 (52) 12.6 0.00** 
Time on waiting list—
weeks (SD) 
11 (22.6)a 7 (10.4) 5 (7.7)a 4.1 0.02* 
% Had previous drug 
treatment 
83 (177) 95 (77) 92 (75) 9.7 0.00** 
Previous treatments         
Methadone maintenance 58 (123) 65 (52) 51 (42) 3.1 0.21 
Structured detoxification 43 (91) 64 (51) 61 (49) 13.3 0.00** 
Residential treatment 22 (46) 33 (27) 58 (47) 35.2 0.00** 
One-to-one counselling 53 (113) 75 (61) 67 (55) 13.8 0.00** 
Note: Levels of significance are shows as *p<0.05; **p<0.01.  
a Means on the same row and sharing the same superscript letter differ significantly at p<0.05 (Tukey HSD 
test). 
 
Table II also shows that participants in the methadone modality were less likely to have previously 
sought treatment for their drug use, and to have presented at all forms of treatment, except 
methadone. Although participants in methadone treatment were less likely to have been on a 
waiting list prior to commencing their index treatment, those that were, spent significantly longer 
waiting to access treatment than their counterparts. 
 
There were no statistically significant differences across modalities in lifetime use or the mean age 
of first use of any illicit substances. However there were significant differences in the proportions 
reporting problematic use of certain drugs. Participants starting methadone treatment were more 
likely to report their heroin use as problematic (x2=8.9, p< 0.05). Conversely, participants in 
abstinence-based programmes were more likely to report problematic use of methadone (x2=23.2, p 
< 0.01), cocaine (x2=21.9, p < 0.01), cannabis (x2=36.8, p < 0.01), and alcohol (x2=25.9, p < 0.01). 
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Table III shows some statistically significant differences in recent (last 90 days) substance use 
across modality. Not only were participants in methadone treatment more likely to have used heroin 
and cannabis but they also reported using both drugs on more days than those in the abstinence 
and detoxification modalities (heroin F=12.3, p < 0.01; cannabis F=3.6, p < 0.05). Participants in the 
abstinence-based modality were less likely to report recent poly-drug use and injecting drug use. 
There were no significant differences in recent injecting risk behaviour across modality, however the 
abstinence group reported higher rates of lifetime risk behaviours: borrowing (x2=18.1, p< 0.01) and 
lending (x2=10.4, p < 0.01) used injecting equipment, and sharing filters/spoons/flush water 
(x2=12.8, p < 0.01). 
 
Table III. Injecting risk behaviour by modality. 
 Modality F/x values p-values   
 Methadone 
(n=215) 
Detoxification 
(n=81) 
Abstinence 
(n=82) 
  
 % n % n % n   
% Used a Heroin 82 (175) 75 (61) 58 (45) 17.8 0.00** 
Methadone 44 (95) 46 (37) 31 (25) 4.9 0.08 
Benzodiazepines 45 (95) 51 (41) 35 (28) 4.4 0.11 
Cocaine 40 (85) 49 (40) 46 (36) 2.7 0.25 
Crack 15 (32) 14 (11) 17 (13) 0.3 0.87 
Cannabis 67 (135) 66 (52) 50 (37) 6.7 0.03* 
Alcohol 54 (108) 57 (46) 55 (41) 0.2 0.91 
% Poly-drug use a 79 (170) 82 (66) 61 (50) 12.4 0.00** 
% Injected a 57 (93) 61 (38) 43 (24) 6.4 0.04* 
% Overdosed a 8 (17) 4 (3) 3 (2) 4.4 0.11 
Note: Levels of significance are shows as *p< 0.05; **p<0.01. a Refers to behaviour in the 90 days preceding 
interview. 
 
The reporting of physical and mental health complaints varied significantly across modality with 
participants in the detoxification group reporting higher rates of physical health complaints while 
those in abstinence-based programme were more likely to report mental health problems. For 
example, respondents in the detoxification group were more likely to report having a poor appetite 
(x2=15.8, p < 0.01), stomach pains (x2=7.6, p < 0.05), chest pains (x2=15.6, p< 0.01), joint or bone 
pains (x2=22.7, p< 0.01), muscle pains (x2=24.0, p < 0.01) and numbness or tingling (x2=8.2, p < 
0.05). Conversely, participants in the abstinence group were more likely to report feeling tense 
(x2=17.3, p < 0.01), suddenly scared for no reason (x2=11.1, p < 0.01), feeling fearful (x2=27.7, p < 
0.01), nervousness or shakiness (x2=21.9, p < 0.01), feelings of worthlessness (x2=10.0, p < 0.05) 
and feeling lonely (x2=10.7, p < 0.01). 
 
Analysis revealed few differences when comparing self-reported crime rates across modalities. That 
said, respondents in the methadone group were less likely to report selling/supplying drugs in the 
preceding 90 days than their counterparts in detoxification and abstinence based treatments 
(x2=11.0, p < 0.01). In addition, participants in abstinence-based treatment reported higher rates of 
assault (x2=11.7, p < 0.01) than those in the other modalities. Individuals in detoxification and 
abstinence-based treatments were more likely to have outstanding legal problems at the time of 
interview. However, greater proportions of participants in these modalities had been in prison in the 
3 months prior to interview (x2=9.7, p< 0.01). 
 
Discussion 
The need for well-designed, planned and executed treatment outcome studies that provide scientific 
evidence on which to base important public-health policy has been well documented across the 
globe (UNDCP, 1997; EMCDDA, 1999) The data presented in this study provides the first such 
evidence in an Irish context. In addition the evidence presented is based on high levels of coverage 
of the treated population and the cohorts demographics broadly reflect the known demographics of 
this population. The study’s 3:1 male to female gender ratio is broadly representative of the overall 
treatment population (Long, Lynn, & Kelly, 2005). In addition 13% of the ROSIE cohort was 
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commencing treatment for the first time. This is comparable with the 12% of ‘new cases’ presenting 
for treatment in the HSE Eastern Region (Kelly, Lynn, & Long, 2005), the area where most ROSIE 
study recruitment occurred. The analysis of the ROSIE baseline data highlights a number of key 
areas of concern, most notably poly-drug use, alcohol use, crime, health and service contact. 
However, as with any research, the results discussed must be viewed in light of any limitations. This 
study did not randomly allocate participants to treatment settings or modality, nor did it employ a 
control group (drug users with similar profile not attending the index treatment). In addition the 
geographical locations of the services chosen reflect the provision of services available at national 
level rather than being a representative sample. While these choices do place limitations on the 
study these limitations are acceptable and reflect similar limitation in other international outcome 
studies. 
 
While the vast majority of study participants were opiate users, poly-drug use was the norm (76%) 
with rates comparable to NTORS (81%; Gossop et al., 1998). A relatively high proportion of 
participants (44%) reported recent (last 90 days) cocaine use. Research suggests that opiate users 
who use cocaine can be distinguished from other opiate users in a number of respects; higher 
frequency of injecting and sexual risk behaviour (Hudgins, McCusker, & Stoddard, 1995), greater 
involvement in crime (Grella, Anglin, & Wugalter, 1997), more alcohol use (Boys, Dobson, Marsden, 
& Strang, 2002), more physical and psychological health problems (Foltin & Fischman, 1998) and 
increased risk of contracting HIV or other blood-borne infectious diseases ( Joe & Simpson, 1995). 
High levels of cocaine use at treatment intake have also been shown to be an independent 
predictor of poor treatment outcomes for opiate users and pose a significant risk for relapse 
(Gossop et al., 2003).  
 
Levels of recent benzodiazepine consumption were also high (44%). Benzodiazepine poly-drug 
users are more likely to inject, to share injecting equipment, and to have higher risks of HIV and 
HCV infection (Drake, 1994; Drake, Hall, Ross, & Wodak, 1992). Use of this class of drugs has also 
been found to be associated with greater psychological morbidity (Rooney, Kelly, Bamford, Sloan, & 
O’Connor, 1999) and to compromise treatment outcomes (Gossop, Stewart, Browne, & Marsden, 
2002). 
 
The ROSIE data confirms that opiate users presenting at treatment services in Ireland are primarily 
a poly-drug using cohort. Data also highlight the increased use of cocaine by this population. 
National drug treatment services must be prepared to respond to service users multiple drug use. 
Research suggests that drug service providers have a tendency to focus on what they perceive as 
being the main illicit problem drug (Miller & Mirin, 1989). Analysis of the ROSIE follow-up data will 
shed some light on whether this applies in the Irish context, the impact of poly-drug use on 
treatment outcomes, and the extent to which treatment services are dealing with service users’ 
multiple drug use. The goals of drug treatment in Ireland are clearly stated in the national drug 
strategy (National Drugs Strategy, 2001). This strategy clearly highlights the four pillars of action, 
supply reduction, prevention, treatment and research. The objective of treatment is two fold. First, to 
enable those dependent on drugs to reduce dependency, improve health and social well being and 
ultimately to lead a drug-free lifestyle and, second, to minimize the harm to those who continue to 
engage in drug taking. The outcomes from the ROSIE study will provide the first evidence on the 
realization of these two objectives.  
 
As with NTORS (Gossop et al., 1998), the drinking patterns among ROSIE participants tend to be 
dichotomous, with relatively high proportions of non-drinkers (46%) and heavy drinkers (40%). 
Excessive alcohol use may present particular problems for opiate users, as the high rates of 
hepatitis B and C infection among this cohort is known to elevate the health risks of excessive 
drinking (Baffis et al., 1999). In addition, alcohol consumption increases the risk of overdose when 
used with other sedative drugs (Gossop, Griffiths, Powis, Williamson, & Strang, 1996). The need to 
identify and respond to drinking problems among opiate users should be clearly and explicitly 
recognized as a requirement of drug treatment services. 
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Regular and dependent use of heroin and/or cocaine is strongly related to drug supply/dealing (Ball, 
Sheffer, & Nurco, 1983) and other income-generating crimes, such as acquisitive crimes ( Jarvis & 
Parker, 1989). Research has indicated that drug treatment plays an important role in reducing some 
types of criminal behaviour (Ball & Ross, 1991; Gossop, 2005). Although reductions in crime are not 
seen as specific goals of drug treatment in Ireland, an effective response to drug-driven acquisitive 
crime requires treatment for drug-related problems. A range of physical (Stein, 1999) and mental 
(Weaver, Madden, Charles, Stimpson, & Renton, 2003) health problems are associated with 
problematic drug use. Study participants reported high rates of physical and mental health 
symptoms and extensive contact with an array of health and social care services, highlighting the 
multiple and often inter-related or complex needs of this cohort.  
 
Research suggests that drug users with ‘complex needs’ are those attending a range of different 
agencies, but are less likely to be helped by any one agency. Such a client group are characterized 
by frequent service use and non-compliance with treatment regimes (Keene, 2001), which may 
have implications for treatment outcomes. Consequently they are a resource-intensive group, which 
provide the greatest challenge for service providers. Analysis revealed some differences in the 
characteristics and problems presented by service users at treatment intake to the three treatment 
modalities.  
 
Participants in the methadone modality were more likely to have no educational qualification, to be 
homeless, and to have children. They were also more likely to report problematic heroin use, and 
the recent use of both heroin and cannabis at treatment intake than participants in other modalities. 
They were, however, less likely to have sought previous treatment for their drug use. Conversely, 
participants in the abstinence-based modality were more likely to be male and to consider their 
methadone, cocaine, cannabis and alcohol use as problematic. Although there was no significant 
difference in lifetime use of each class of drugs, individuals in the abstinence-based modality were 
more likely to have reported lifetime injecting risk behaviours. These participants were also more 
likely to report suffering from mental health problems and to have outstanding legal charges. On the 
other hand, individuals commencing a structured detoxification programme were younger than their 
counterparts. They were more likely to report recent poly-drug use and injecting drug use. 
Respondents in this modality were also more likely to report physical health problems at the time of 
interview. The identified differences across modality may be due to a mixture of service referral and 
self-selection processes. 
 
Analysis of ROSIE baseline data demonstrates the extent to which service users in the Irish drug 
treatment system present with multiple problems, many of which are both severe and chronic. The 
range and severity of these problems present major challenges for the services, which have primary 
responsibility for their management and treatment. The data presented here shows that many 
agencies are brought into contact with problem drug users. There is an urgent need to ensure the 
provision of an integrated and co-ordinated response to problem drug use. In addition, it is crucial 
that different drug treatment services are effectively co-ordinated and that appropriate support is 
obtained from a wide range of other agencies. This is ever more important in the changing, dynamic 
and growing multicultural Irish society of today. To capture the longer term influences on treatment 
outcomes the ROSIE study has recently been extended to allow for a continuing follow-up of study 
participants over a three-year follow-up period and future reports will present data on the impact of 
treatment upon the problems described in this paper. 
 
 
 
Please use the following citation: Cox G and Comiskey C (2007) Characteristics of opiate users presenting for a new treatment episode: 
Baseline data from the national drug treatment outcome study in Ireland (ROSIE), (Author postprint) in Drugs: education, prevention and 
policy, 14(3): 217–230 [Accessed: (date) from www.drugsandalcohol.ie]   
 
9
Acknowledgements 
We thank the National Advisory Commission on Drugs (NACD) for commissioning and funding the 
ROSIE study and in particular the Director Mairead Lyons for her commitment to the research. We 
are indebted to Jennifer Cronly for her assistance in drafting this article. We would also like to thank 
Dr Gloria Crispino-O’Connell (Institute of Technology, Tallaght) Paul Kelly (NUI, Maynooth) and 
Emma White (NUI Maynooth) for their statistical advice on the study. We are particularly grateful to 
the staff at the 54 services where study recruitment was undertaken, without their support and co-
operation the ROSIE study would not have been possible. In addition, we are indebted to all service 
users who agreed to take part in the ROSIE study. 
 
 
 
References 
Anglin, M., Hser, Y. I., & Grella, C. (1997). Drug addition and treatment careers among clients in the 
drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviour, 11, 308–
323. 
Baffis, V., Shrier, I., Sherker, A. H., & Szilagyi, A. (1999). Use of interferon for prevention of 
hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C infection. Annual 
International Medicine, 131, 696–701. 
Ball, J., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York: 
Springer. 
Ball, J., Sheffer, J. W., & Nurco, D. N. (1983). The day-to-day criminality of heroin addicts in 
Baltimore: A study in the continuity of offence rates. Drug & Alcohol Dependence, 12, 119–142. 
Boys, A., Dobson, J., Marsden, J., & Strang, J. (2002). ‘Rich man’s speed’: A qualitative study of 
young cocaine users. Drugs: Education, Prevention & Policy, 9, 195–210. 
Comiskey, C. (2001). Methods for estimating prevalence of opiate use as an aid to policy and 
planning. Substance Use & Misuse, 36, 131–151. 
Del Coca, F., & Noll, J. (2000). Truth or consequences: The validity of self-report data on health 
service research on addiction. Addiction, 95, S347–S360. 
Drake, S. (1994). Benzodiazepine use among injecting drug users and implications. Addiction, 89, 
379–382. 
Drake, S., Hall, W., Ross, M., & Wodak, A. (1992). Benzodiazepine use and HIV risk-taking 
behaviour among injecting drug users. Drug & Alcohol Dependence, 31, 31–36. 
EMCDDA. (1999). Evaluating the treatment of drug abuse in the European Union (Scientific 
Monograph Series, No. 3). Lisbon, Portugal: European Monitoring Centre for Drugs and Drug 
Addiction. 
Foltin, R., & Fischman, W. (1998). Effects of ‘binge’ use of intravenous cocaine in methadone-
maintained individuals. Addiction, 93, 825–836. 
Gossop, M., Trakada, K., Stewart, D., & Witton, J. (2005). Reductions in criminal convictions after 
addiction traeatment: 5 year follow-up. Drug and Alcohol Dependence, Sep 1, 79, 295–302. 
Gossop, M., Griffiths, P., Powis, B., Williamson, S., & Strang, J. (1996). Frequency of non-fatal 
overdose: Survey of heroin users recruited in non-clinical settings. British Medical Journal, 17, 
313–402. 
Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003). The National Treatment Research Study 
(NTORS): 4–5 year follow-up results. Addiction, 98, 291–303. 
Gossop, M., Marsden, J., Stewart, D., Lehmann, P., Edwards, C., Wilson, A., et al. (1998). 
Substance use, health and social problems of service users at 54 drug treatment agencies. 
British Journal of Psychiatry, 73, 166–171. 
Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2002). Factors associated with abstinence, 
lapse, or relapse to heroin use after residential treatment: Protective effect of coping responses  
Addiction, 97, 1259–1267. 
Grella, C., Anglin, M., & Wugalter, S. (1997). Patterns and predictors of cocaine and crack use by 
clients in standard and enhanced methadone maintenance treatment. American Journal of Drug 
& Alcohol Abuse, 23, 15–42. 
Please use the following citation: Cox G and Comiskey C (2007) Characteristics of opiate users presenting for a new treatment episode: 
Baseline data from the national drug treatment outcome study in Ireland (ROSIE), (Author postprint) in Drugs: education, prevention and 
policy, 14(3): 217–230 [Accessed: (date) from www.drugsandalcohol.ie]   
 
10
Hubbard, R., Craddock, S., Flynn, P., Anderson, J., & Etheridge, R. (1997). Outcomes of one year 
follow-up outcome in Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive 
Behaviour, 11, 261–278. 
Hudgins, R., McCusker, J., & Stoddard, A. (1995). Cocaine use and risky injection and sexual 
behaviours. Drug & Alcohol Dependence, 37, 7–14. 
Jarvis, G., & Parker, H. (1989). Young heroin users and crime: How do the ‘new users’ finance their 
habits? British Journal of Criminology, 29, 175–185. 
Joe, G., & Simpson, D. (1995). HIV risk, gender and cocaine use among opiate users. Drug & 
Alcohol Dependence, 37, 23–28. 
Keene, J. (2001). Clients with complex needs: Inter-professional practice. Oxford, UK: Blackwell 
Science. 
Kelly, A., Carvalho, M., & Teljeur, C. (2003). Prevalence of opiate use in Ireland 2000–2001: A 3-
source capture recapture study. Department of Public Health & Primary Care, NACD. Dublin, 
Ireland: Stationery Office. 
Kelly, F., Lynn, E., & Long, J. (2005). Treatment demand in the Health Service Executive Eastern 
Region, 1998 to 2002 (Occasional Paper 15). Dublin, Ireland: Health Research Board. 
Long, J., Lynn, E., & Kelly, F. (2005). Trends in treated problem drug users in Ireland, 1998 to 2002 
(Occasional Paper 17). Dublin, Ireland: Health Research Board. 
Miller, N., & Mirin, S. (1989). Multiple drug use in alcoholics: Practical and theoretical implications. 
Psychiatric Annals, 19, 251–255. 
National Drugs Strategy. (2001). Building on experience 2001–2008. Department of Tourism, Sport 
and Recreation. Dublin, Ireland: Stationery Office. 
Rooney, S., Kelly, G., Bamford, D., Sloan, D., & O’Connor, J. (1999). Co-abuse of opiates and 
benzodiazepines. Irish Journal of Medical Science, 168, 37–41. 
Stein, M. D. (1999). Medical consequences of substances abuse. Psychiatric Clinics of North 
America, 22, 351–370. 
Teesson, M., Ross, J., Drake, S., Lynskey, M., Ali, R., Ritter, A., et al. (2006). One year outcomes 
for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS).Drug & 
Alcohol Dependence, 83, 174–180. 
UNDCP. (1997). World drug report. United Nations Drug Control Programs. Oxford, UK: Oxford 
University Press. 
Weaver, T., Madden, P., Charles, V., Stimpson, G., & Renton, A. (2003). Co-morbidity of substance 
misuse and mental illness in community mental health and substance misuse services. British 
Journal of Psychiatry, 183, 304–313. 
 
